vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Life Time Group Holdings, Inc. (LTH). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $745.1M, roughly 1.3× Life Time Group Holdings, Inc.). Life Time Group Holdings, Inc. runs the higher net margin — 16.5% vs 0.7%, a 15.8% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 12.3%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-64.6M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 11.7%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Life Time Group Holdings, Inc. operates a network of premium athletic, fitness and wellness destinations across the United States. It offers diverse services including state-of-the-art gym facilities, group exercise classes, personal training, spa treatments, nutrition coaching, youth programs and co-working spaces for consumers pursuing holistic healthy lifestyles.
ASTH vs LTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $745.1M |
| Net Profit | $6.6M | $123.0M |
| Gross Margin | — | 49.1% |
| Operating Margin | 1.9% | 17.4% |
| Net Margin | 0.7% | 16.5% |
| Revenue YoY | 42.9% | 12.3% |
| Net Profit YoY | 184.4% | 231.0% |
| EPS (diluted) | $0.12 | $0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $745.1M | ||
| Q3 25 | $956.0M | $782.6M | ||
| Q2 25 | $654.8M | $761.5M | ||
| Q1 25 | $620.4M | $706.0M | ||
| Q4 24 | $665.2M | $663.3M | ||
| Q3 24 | $478.7M | $693.2M | ||
| Q2 24 | $486.3M | $667.8M | ||
| Q1 24 | $404.4M | $596.7M |
| Q4 25 | $6.6M | $123.0M | ||
| Q3 25 | $373.0K | $102.4M | ||
| Q2 25 | $9.4M | $72.1M | ||
| Q1 25 | $6.7M | $76.1M | ||
| Q4 24 | $-7.8M | $37.2M | ||
| Q3 24 | $16.1M | $41.4M | ||
| Q2 24 | $19.2M | $52.8M | ||
| Q1 24 | $14.8M | $24.9M |
| Q4 25 | — | 49.1% | ||
| Q3 25 | — | 47.1% | ||
| Q2 25 | — | 47.0% | ||
| Q1 25 | — | 47.5% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | — | 46.5% | ||
| Q2 24 | — | 46.8% | ||
| Q1 24 | — | 46.1% |
| Q4 25 | 1.9% | 17.4% | ||
| Q3 25 | 2.0% | 17.3% | ||
| Q2 25 | 3.1% | 14.2% | ||
| Q1 25 | 3.3% | 15.2% | ||
| Q4 24 | 0.1% | 13.1% | ||
| Q3 24 | 5.9% | 13.5% | ||
| Q2 24 | 6.2% | 15.7% | ||
| Q1 24 | 7.5% | 12.1% |
| Q4 25 | 0.7% | 16.5% | ||
| Q3 25 | 0.0% | 13.1% | ||
| Q2 25 | 1.4% | 9.5% | ||
| Q1 25 | 1.1% | 10.8% | ||
| Q4 24 | -1.2% | 5.6% | ||
| Q3 24 | 3.4% | 6.0% | ||
| Q2 24 | 3.9% | 7.9% | ||
| Q1 24 | 3.7% | 4.2% |
| Q4 25 | $0.12 | $0.55 | ||
| Q3 25 | $0.01 | $0.45 | ||
| Q2 25 | $0.19 | $0.32 | ||
| Q1 25 | $0.14 | $0.34 | ||
| Q4 24 | $-0.14 | $0.17 | ||
| Q3 24 | $0.33 | $0.19 | ||
| Q2 24 | $0.40 | $0.26 | ||
| Q1 24 | $0.31 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $204.8M |
| Total DebtLower is stronger | — | $1.5B |
| Stockholders' EquityBook value | $779.3M | $3.1B |
| Total Assets | $2.2B | $8.0B |
| Debt / EquityLower = less leverage | — | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $204.8M | ||
| Q3 25 | $463.4M | $218.9M | ||
| Q2 25 | $342.1M | $175.5M | ||
| Q1 25 | $260.9M | $59.0M | ||
| Q4 24 | $290.8M | $10.9M | ||
| Q3 24 | $350.3M | $120.9M | ||
| Q2 24 | $327.7M | $34.5M | ||
| Q1 24 | $337.3M | $18.6M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $2.0B |
| Q4 25 | $779.3M | $3.1B | ||
| Q3 25 | $775.5M | $3.0B | ||
| Q2 25 | $765.5M | $2.9B | ||
| Q1 25 | $745.4M | $2.7B | ||
| Q4 24 | $712.7M | $2.6B | ||
| Q3 24 | $704.6M | $2.6B | ||
| Q2 24 | $678.9M | $2.4B | ||
| Q1 24 | $653.5M | $2.3B |
| Q4 25 | $2.2B | $8.0B | ||
| Q3 25 | $2.2B | $7.8B | ||
| Q2 25 | $1.4B | $7.6B | ||
| Q1 25 | $1.3B | $7.3B | ||
| Q4 24 | $1.4B | $7.2B | ||
| Q3 24 | $1.3B | $7.2B | ||
| Q2 24 | $1.3B | $7.1B | ||
| Q1 24 | $1.2B | $7.1B |
| Q4 25 | — | 0.48× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 0.59× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $239.9M |
| Free Cash FlowOCF − Capex | $-6.0M | $-64.6M |
| FCF MarginFCF / Revenue | -0.6% | -8.7% |
| Capex IntensityCapex / Revenue | 0.3% | 40.9% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.95× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $-21.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $239.9M | ||
| Q3 25 | $10.0M | $251.1M | ||
| Q2 25 | $90.9M | $195.7M | ||
| Q1 25 | $16.6M | $183.9M | ||
| Q4 24 | $-10.9M | $163.1M | ||
| Q3 24 | $34.0M | $151.1M | ||
| Q2 24 | $23.2M | $170.4M | ||
| Q1 24 | $6.0M | $90.4M |
| Q4 25 | $-6.0M | $-64.6M | ||
| Q3 25 | $7.4M | $28.6M | ||
| Q2 25 | $89.5M | $-26.3M | ||
| Q1 25 | $13.6M | $41.4M | ||
| Q4 24 | $-13.5M | $26.8M | ||
| Q3 24 | $31.7M | $64.0M | ||
| Q2 24 | $20.4M | $26.1M | ||
| Q1 24 | $5.6M | $-66.4M |
| Q4 25 | -0.6% | -8.7% | ||
| Q3 25 | 0.8% | 3.7% | ||
| Q2 25 | 13.7% | -3.5% | ||
| Q1 25 | 2.2% | 5.9% | ||
| Q4 24 | -2.0% | 4.0% | ||
| Q3 24 | 6.6% | 9.2% | ||
| Q2 24 | 4.2% | 3.9% | ||
| Q1 24 | 1.4% | -11.1% |
| Q4 25 | 0.3% | 40.9% | ||
| Q3 25 | 0.3% | 28.4% | ||
| Q2 25 | 0.2% | 29.2% | ||
| Q1 25 | 0.5% | 20.2% | ||
| Q4 24 | 0.4% | 20.6% | ||
| Q3 24 | 0.5% | 12.6% | ||
| Q2 24 | 0.6% | 21.6% | ||
| Q1 24 | 0.1% | 26.3% |
| Q4 25 | -0.44× | 1.95× | ||
| Q3 25 | 26.69× | 2.45× | ||
| Q2 25 | 9.65× | 2.71× | ||
| Q1 25 | 2.48× | 2.41× | ||
| Q4 24 | — | 4.39× | ||
| Q3 24 | 2.11× | 3.65× | ||
| Q2 24 | 1.21× | 3.23× | ||
| Q1 24 | 0.40× | 3.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
LTH
| Membership | $535.1M | 72% |
| In Center | $191.2M | 26% |
| Other | $18.8M | 3% |
